Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Seth Paul Finklestein, M.D.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AG008207 (FINKLESTEIN, SETH P) Jul 1, 1988 - Jun 30, 1995
    NIH
    FIBROBLAST GROWTH FACTORS IN THE AGING BRAIN
    Role: Principal Investigator
  2. P50NS010828 (MOSKOWITZ, MICHAEL) Feb 1, 1977 - Apr 30, 2009
    NIH
    Interdepartmental Stroke Program
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lin DJ, Erler KS, Snider SB, Bonkhoff AK, DiCarlo JA, Lam N, Ranford J, Parlman K, Cohen A, Freeburn J, Finklestein SP, Schwamm LH, Hochberg LR, Cramer SC. Cognitive Demands Influence Upper Extremity Motor Performance During Recovery From Acute Stroke. Neurology. 2021 05 25; 96(21):e2576-e2586. PMID: 33858997.
    Citations:    Fields:    Translation:Humans
  2. Go V, Sarikaya D, Zhou Y, Bowley BGE, Pessina MA, Rosene DL, Zhang ZG, Chopp M, Finklestein SP, Medalla M, Buller B, Moore TL. Extracellular vesicles derived from bone marrow mesenchymal stem cells enhance myelin maintenance after cortical injury in aged rhesus monkeys. Exp Neurol. 2021 03; 337:113540. PMID: 33264634.
    Citations:    Fields:    
  3. Page SJ, Kasner SE, Bockbrader M, Goldstein M, Finklestein SP, Ning M, El-Feky WH, Wilson CA, Roberts H. A double-blind, randomized, controlled study of two dose strengths of dalfampridine extended release on walking deficits in ischemic stroke. Restor Neurol Neurosci. 2020; 38(4):301-309. PMID: 32651338.
    Citations:    Fields:    Translation:Humans
  4. Go V, Bowley BGE, Pessina MA, Zhang ZG, Chopp M, Finklestein SP, Rosene DL, Medalla M, Buller B, Moore TL. Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys. Geroscience. 2020 02; 42(1):1-17. PMID: 31691891.
    Citations: 21     Fields:    Translation:AnimalsCells
  5. Lin DJ, Cloutier AM, Erler KS, Cassidy JM, Snider SB, Ranford J, Parlman K, Giatsidis F, Burke JF, Schwamm LH, Finklestein SP, Hochberg LR, Cramer SC. Corticospinal Tract Injury Estimated From Acute Stroke Imaging Predicts Upper Extremity Motor Recovery After Stroke. Stroke. 2019 12; 50(12):3569-3577. PMID: 31648631.
    Citations: 9     Fields:    Translation:Humans
  6. Orczykowski ME, Calderazzo SM, Shobin E, Pessina MA, Oblak AL, Finklestein SP, Kramer BC, Mortazavi F, Rosene DL, Moore TL. Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury. Brain Res. 2019 08 15; 1717:147-159. PMID: 30998931.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  7. Moore TL, Bowley BGE, Pessina MA, Calderazzo SM, Medalla M, Go V, Zhang ZG, Chopp M, Finklestein S, Harbaugh AG, Rosene DL, Buller B. Mesenchymal derived exosomes enhance recovery of motor function in a monkey model of cortical injury. Restor Neurol Neurosci. 2019; 37(4):347-362. PMID: 31282441.
    Citations: 9     Fields:    Translation:AnimalsCells
  8. Lin DJ, Finklestein SP, Cramer SC. New Directions in Treatments Targeting Stroke Recovery. Stroke. 2018 12; 49(12):3107-3114. PMID: 30571435.
    Citations: 12     Fields:    Translation:Humans
  9. Orczykowski ME, Arndt KR, Palitz LE, Kramer BC, Pessina MA, Oblak AL, Finklestein SP, Mortazavi F, Rosene DL, Moore TL. Cell based therapy enhances activation of ventral premotor cortex to improve recovery following primary motor cortex injury. Exp Neurol. 2018 07; 305:13-25. PMID: 29540323.
    Citations: 5     Fields:    Translation:HumansAnimals
  10. Bosetti F, Koenig JI, Ayata C, Back SA, Becker K, Broderick JP, Carmichael ST, Cho S, Cipolla MJ, Corbett D, Corriveau RA, Cramer SC, Ferguson AR, Finklestein SP, Ford BD, Furie KL, Hemmen TM, Iadecola C, Jakeman LB, Janis S, Jauch EC, Johnston KC, Kochanek PM, Kohn H, Lo EH, Lyden PD, Mallard C, McCullough LD, McGavern LM, Meschia JF, Moy CS, Perez-Pinzon MA, Ramadan I, Savitz SI, Schwamm LH, Steinberg GK, Stenzel-Poore MP, Tymianski M, Warach S, Wechsler LR, Zhang JH, Koroshetz W. Translational Stroke Research: Vision and Opportunities. Stroke. 2017 09; 48(9):2632-2637. PMID: 28751554.
    Citations: 34     Fields:    Translation:HumansAnimals
  11. Moore TL, Pessina MA, Finklestein SP, Killiany RJ, Bowley B, Benowitz L, Rosene DL. Inosine enhances recovery of grasp following cortical injury to the primary motor cortex of the rhesus monkey. Restor Neurol Neurosci. 2016 09 21; 34(5):827-48. PMID: 27497459.
    Citations: 4     Fields:    Translation:HumansAnimals
  12. Iaci JF, Parry TJ, Huang Z, Pavlopoulos E, Finklestein SP, Ren J, Caggiano A. An optimized dosing regimen of cimaglermin (neuregulin 1ß3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats. J Neurosci Res. 2016 Mar; 94(3):253-65. PMID: 26660233.
    Citations: 6     Fields:    Translation:Animals
  13. Kulkarni P, Kenkel W, Finklestein SP, Barchet TM, Ren J, Davenport M, Shenton ME, Kikinis Z, Nedelman M, Ferris CF. Use of Anisotropy, 3D Segmented Atlas, and Computational Analysis to Identify Gray Matter Subcortical Lesions Common to Concussive Injury from Different Sites on the Cortex. PLoS One. 2015; 10(5):e0125748. PMID: 25955025.
    Citations: 8     Fields:    Translation:Animals
  14. Moore TL, Pessina MA, Finklestein SP, Kramer BC, Killiany RJ, Rosene DL. Recovery of fine motor performance after ischemic damage to motor cortex is facilitated by cell therapy in the rhesus monkey. Somatosens Mot Res. 2013 Dec; 30(4):185-96. PMID: 23758412.
    Citations: 12     Fields:    Translation:Animals
  15. Iaci JF, Parry TJ, Huang Z, Finklestein SP, Ren J, Barrile DK, Davenport MD, Wu R, Blight AR, Caggiano AO. Dalfampridine improves sensorimotor function in rats with chronic deficits after middle cerebral artery occlusion. Stroke. 2013 Jul; 44(7):1942-50. PMID: 23652269.
    Citations: 6     Fields:    Translation:Animals
  16. Menniti FS, Ren J, Sietsma DK, Som A, Nelson FR, Stephenson DT, Tate BA, Finklestein SP. A non-brain penetrant PDE5A inhibitor improves functional recovery after stroke in rats. Restor Neurol Neurosci. 2012; 30(4):283-9. PMID: 22596355.
    Citations: 1     Fields:    Translation:Animals
  17. Moore TL, Killiany RJ, Pessina MA, Moss MB, Finklestein SP, Rosene DL. Recovery from ischemia in the middle-aged brain: a nonhuman primate model. Neurobiol Aging. 2012 Mar; 33(3):619.e9-619.e24. PMID: 21458887.
    Citations: 19     Fields:    Translation:Animals
  18. Iaci JF, Ganguly A, Finklestein SP, Parry TJ, Ren J, Saha S, Sietsma DK, Srinivas M, Vecchione AM, Caggiano AO. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke. Neuropharmacology. 2010 Dec; 59(7-8):640-9. PMID: 20691195.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  19. Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Stroke: working toward a prioritized world agenda. Int J Stroke. 2010 Aug; 5(4):238-56. PMID: 20636706.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  20. Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Stroke: working toward a prioritized world agenda. Stroke. 2010 Jun; 41(6):1084-99. PMID: 20498453.
    Citations: 27     Fields:    Translation:HumansAnimals
  21. Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Stroke: working toward a prioritized world agenda. Cerebrovasc Dis. 2010; 30(2):127-47. PMID: 20516682.
    Citations: 5     Fields:    Translation:Humans
  22. Menniti FS, Ren J, Coskran TM, Liu J, Morton D, Sietsma DK, Som A, Stephenson DT, Tate BA, Finklestein SP. Phosphodiesterase 5A inhibitors improve functional recovery after stroke in rats: optimized dosing regimen with implications for mechanism. J Pharmacol Exp Ther. 2009 Dec; 331(3):842-50. PMID: 19729580.
    Citations: 10     Fields:    Translation:AnimalsCells
  23. Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, Finklestein SP, Pangalos MN, Poole M, Stiles GL, Ruffolo RR, Walsh FL. Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab. 2008 Jan; 28(1):217-9. PMID: 17579658.
    Citations: 56     Fields:    Translation:Humans
  24. Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke. 2007 Apr; 38(4):1393-5. PMID: 17332455.
    Citations: 32     Fields:    Translation:Humans
  25. Ren J, Sietsma D, Qiu S, Moessler H, Finklestein SP. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Restor Neurol Neurosci. 2007; 25(1):25-31. PMID: 17473393.
    Citations: 17     Fields:    Translation:Animals
  26. Yu LJ, Riordan B, Hatsis P, Brockman A, Daniels S, Stagliano N, Finklestein S, Ren J, Milton M, Miwa G. Study of brain and whole blood PK/PD of bortezomib in rat models. J Clin Oncol. 2006 Jun 20; 24(18_suppl):12036. PMID: 27953058.
    Citations:    
  27. Romero JR, Babikian VL, Katz DI, Finklestein SP. Neuroprotection and stroke rehabilitation: modulation and enhancement of recovery. Behav Neurol. 2006; 17(1):17-24. PMID: 16720957.
    Citations: 4     Fields:    Translation:Humans
  28. Ren JM, Finklestein SP. Growth factor treatment of stroke. Curr Drug Targets CNS Neurol Disord. 2005 Apr; 4(2):121-5. PMID: 15857297.
    Citations: 18     Fields:    Translation:HumansAnimals
  29. Berry D, Ren J, Kwan CP, Sietsma DK, Sasisekharan R, Finklestein SP. Dimeric fibroblast growth factor-2 enhances functional recovery after focal cerebral ischemia. Restor Neurol Neurosci. 2005; 23(3-4):251-6. PMID: 16082081.
    Citations: 7     Fields:    Translation:Animals
  30. Kong KY, Ren J, Kraus M, Finklestein SP, Brown RH. Human umbilical cord blood cells differentiate into muscle in sjl muscular dystrophy mice. Stem Cells. 2004; 22(6):981-93. PMID: 15536189.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  31. Wada K, Sugimori H, Bhide PG, Moskowitz MA, Finklestein SP. Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats. Stroke. 2003 Nov; 34(11):2722-8. PMID: 14576381.
    Citations: 17     Fields:    Translation:AnimalsCells
  32. Cairns K, Finklestein SP. Growth factors and stem cells as treatments for stroke recovery. Phys Med Rehabil Clin N Am. 2003 Feb; 14(1 Suppl):S135-42. PMID: 12625643.
    Citations: 14     Fields:    Translation:Humans
  33. Dijkhuizen RM, Singhal AB, Mandeville JB, Wu O, Halpern EF, Finklestein SP, Rosen BR, Lo EH. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci. 2003 Jan 15; 23(2):510-7. PMID: 12533611.
    Citations: 101     Fields:    Translation:Animals
  34. Schaechter JD, Kraft E, Hilliard TS, Dijkhuizen RM, Benner T, Finklestein SP, Rosen BR, Cramer SC. Motor recovery and cortical reorganization after constraint-induced movement therapy in stroke patients: a preliminary study. Neurorehabil Neural Repair. 2002 Dec; 16(4):326-38. PMID: 12462764.
    Citations: 55     Fields:    Translation:HumansCTClinical Trials
  35. Cramer SC, Weisskoff RM, Schaechter JD, Nelles G, Foley M, Finklestein SP, Rosen BR. Motor cortex activation is related to force of squeezing. Hum Brain Mapp. 2002 Aug; 16(4):197-205. PMID: 12112762.
    Citations: 44     Fields:    Translation:Humans
  36. Dijkhuizen RM, Ren J, Mandeville JB, Wu O, Ozdag FM, Moskowitz MA, Rosen BR, Finklestein SP. Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc Natl Acad Sci U S A. 2001 Oct 23; 98(22):12766-71. PMID: 11606760.
    Citations: 88     Fields:    Translation:Animals
  37. Labowitz J, Finklestein S, Rabinovitz M. Postinfantile giant cell hepatitis complicating ulcerative colitis: a case report and review of the literature. Am J Gastroenterol. 2001 Apr; 96(4):1274-7. PMID: 11316183.
    Citations: 3     Fields:    Translation:HumansCells
  38. Sugimori H, Speller H, Finklestein SP. Intravenous basic fibroblast growth factor produces a persistent reduction in infarct volume following permanent focal ischemia in rats. Neurosci Lett. 2001 Mar 02; 300(1):13-6. PMID: 11172928.
    Citations: 9     Fields:    Translation:HumansAnimals
  39. Arnett DK, Glasser SP, McVeigh G, Prineas R, Finklestein S, Donahue R, Cohn JN, Sinaiko A. Blood pressure and arterial compliance in young adults: the Minnesota Children's Blood Pressure Study. Am J Hypertens. 2001 Mar; 14(3):200-5. PMID: 11281229.
    Citations: 15     Fields:    Translation:Humans
  40. Ay I, Sugimori H, Finklestein SP. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res. 2001 Feb 19; 87(1):71-80. PMID: 11223161.
    Citations: 16     Fields:    Translation:AnimalsCells
  41. Cramer SC, Nelles G, Schaechter JD, Kaplan JD, Finklestein SP, Rosen BR. A functional MRI study of three motor tasks in the evaluation of stroke recovery. Neurorehabil Neural Repair. 2001; 15(1):1-8. PMID: 11527274.
    Citations: 17     Fields:    Translation:Humans
  42. Ren J, Kaplan PL, Charette MF, Speller H, Finklestein SP. Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke. Neuropharmacology. 2000 Mar 03; 39(5):860-5. PMID: 10699451.
    Citations: 22     Fields:    Translation:Animals
  43. Cramer SC, Moore CI, Finklestein SP, Rosen BR. A pilot study of somatotopic mapping after cortical infarct. Stroke. 2000 Mar; 31(3):668-71. PMID: 10700502.
    Citations: 32     Fields:    Translation:Humans
  44. Upton-Rice MN, Cudkowicz ME, Warren L, Mathew RK, Ren JM, Finklestein SP, Brown RH. Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol. 1999 Dec; 46(6):934. PMID: 10589551.
    Citations: 2     Fields:    Translation:HumansAnimals
  45. Kawamata T, Ren J, Cha JH, Finklestein SP. Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal stroke. Exp Neurol. 1999 Jul; 158(1):89-96. PMID: 10448420.
    Citations: 6     Fields:    Translation:AnimalsCells
  46. Ay H, Ay I, Koroshetz WJ, Finklestein SP. Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc Dis. 1999 May-Jun; 9(3):131-5. PMID: 10207203.
    Citations: 16     Fields:    Translation:AnimalsCells
  47. Ramirez JJ, Finklestein SP, Keller J, Abrams W, George MN, Parakh T. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport. 1999 Apr 26; 10(6):1201-4. PMID: 10363924.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  48. Fisher M, Finklestein S. Pharmacological approaches to stroke recovery. Cerebrovasc Dis. 1999; 9 Suppl 5:29-32. PMID: 10473918.
    Citations: 1     Fields:    Translation:Humans
  49. Cramer SC, Finklestein SP, Schaechter JD, Bush G, Rosen BR. Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements. J Neurophysiol. 1999 Jan; 81(1):383-7. PMID: 9914297.
    Citations: 72     Fields:    Translation:HumansCTClinical Trials
  50. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab. 1998 Nov; 18(11):1253-8. PMID: 9809515.
    Citations: 133     Fields:    Translation:HumansAnimals
  51. Nelles G, Cramer SC, Schaechter JD, Kaplan JD, Finklestein SP. Quantitative assessment of mirror movements after stroke. Stroke. 1998 Jun; 29(6):1182-7. PMID: 9626292.
    Citations: 36     Fields:    Translation:Humans
  52. Kawamata T, Ren J, Chan TC, Charette M, Finklestein SP. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport. 1998 May 11; 9(7):1441-5. PMID: 9631444.
    Citations: 13     Fields:    Translation:HumansAnimals
  53. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK, Kennedy DN, Finklestein SP, Rosen BR. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke. 1997 Dec; 28(12):2518-27. PMID: 9412643.
    Citations: 214     Fields:    Translation:Humans
  54. Cramer SC, Nelles G, Schaechter JD, Kaplan JD, Finklestein SP. Computerized measurement of motor performance after stroke. Stroke. 1997 Nov; 28(11):2162-8. PMID: 9368558.
    Citations: 8     Fields:    Translation:Humans
  55. Francis JW, Ren J, Warren L, Brown RH, Finklestein SP. Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats. Exp Neurol. 1997 Aug; 146(2):435-43. PMID: 9270054.
    Citations: 19     Fields:    Translation:HumansAnimals
  56. Kawamata T, Dietrich WD, Schallert T, Gotts JE, Cocke RR, Benowitz LI, Finklestein SP. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci U S A. 1997 Jul 22; 94(15):8179-84. PMID: 9223335.
    Citations: 48     Fields:    Translation:AnimalsCells
  57. Ren JM, Finklestein SP. Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia. Eur J Pharmacol. 1997 May 26; 327(1):11-6. PMID: 9185830.
    Citations: 5     Fields:    Translation:Animals
  58. McDermott KL, Raghupathi R, Fernandez SC, Saatman KE, Protter AA, Finklestein SP, Sinson G, Smith DH, McIntosh TK. Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J Neurotrauma. 1997 Apr; 14(4):191-200. PMID: 9151768.
    Citations: 10     Fields:    Translation:AnimalsCells
  59. Huang Z, Chen K, Huang PL, Finklestein SP, Moskowitz MA. bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice. Am J Physiol. 1997 Mar; 272(3 Pt 2):H1401-5. PMID: 9087617.
    Citations: 4     Fields:    Translation:Animals
  60. Bethel A, Kirsch JR, Koehler RC, Finklestein SP, Traystman RJ. Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke. 1997 Mar; 28(3):609-15; discussion 615-6. PMID: 9056620.
    Citations: 14     Fields:    Translation:Animals
  61. Kawamata T, Speliotes EK, Finklestein SP. The role of polypeptide growth factors in recovery from stroke. Adv Neurol. 1997; 73:377-82. PMID: 8959227.
    Citations: 11     Fields:    Translation:HumansAnimals
  62. Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci. 1996 Aug; 139(2):173-9. PMID: 8856649.
    Citations: 7     Fields:    Translation:AnimalsCells
  63. Speliotes EK, Caday CG, Do T, Weise J, Kowall NW, Finklestein SP. Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res Mol Brain Res. 1996 Jul; 39(1-2):31-42. PMID: 8804711.
    Citations: 8     Fields:    Translation:Animals
  64. Kawamata T, Alexis NE, Dietrich WD, Finklestein SP. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab. 1996 Jul; 16(4):542-7. PMID: 8964792.
    Citations: 24     Fields:    Translation:Animals
  65. Greenberg SM, Finklestein SP, Schaefer PW. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology. 1996 Jun; 46(6):1751-4. PMID: 8649586.
    Citations: 44     Fields:    Translation:Humans
  66. Dietrich WD, Alonso O, Busto R, Finklestein SP. Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats. J Neurotrauma. 1996 Jun; 13(6):309-16. PMID: 8835798.
    Citations: 18     Fields:    Translation:HumansAnimals
  67. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, Can U, Moreira JA, Copen WA, Look RB, Finklestein SP, Rosen BR, Koroshetz WJ. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology. 1996 May; 199(2):391-401. PMID: 8668784.
    Citations: 126     Fields:    Translation:Humans
  68. Speliotes EK, Kowall NW, Shanti BF, Kosofsky B, Finklestein SP, Leifer D. Myocyte-specific enhancer binding factor 2C expression in gerbil brain following global cerebral ischemia. Neuroscience. 1996 Jan; 70(1):67-77. PMID: 8848137.
    Citations: 5     Fields:    Translation:AnimalsCells
  69. Finklestein SP. The potential use of neurotrophic growth factors in the treatment of cerebral ischemia. Adv Neurol. 1996; 71:413-7; discussion 417-8. PMID: 8790816.
    Citations: 5     Fields:    Translation:Animals
  70. Fisher M, Meadows ME, Do T, Weise J, Trubetskoy V, Charette M, Finklestein SP. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1995 Nov; 15(6):953-9. PMID: 7593356.
    Citations: 20     Fields:    Translation:Animals
  71. Kirschner PB, Henshaw R, Weise J, Trubetskoy V, Finklestein S, Schulz JB, Beal MF. Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab. 1995 Jul; 15(4):619-23. PMID: 7790410.
    Citations: 8     Fields:    Translation:AnimalsCells
  72. Koketsu N, Berlove DJ, Moskowitz MA, Kowall NW, Caday CG, Finklestein SP. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann Neurol. 1994 Apr; 35(4):451-7. PMID: 8154872.
    Citations: 13     Fields:    Translation:Animals
  73. Rosenblatt S, Irikura K, Caday CG, Finklestein SP, Moskowitz MA. Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab. 1994 Jan; 14(1):70-4. PMID: 8263060.
    Citations: 10     Fields:    Translation:Animals
  74. Stahlinski CR, Friedman FP, Finklestein S. Brachytherapy: a minimally invasive option for treating prostate cancer. Minim Invasive Surg Nurs. 1994; 8(3):106-9. PMID: 7812389.
    Citations:    Fields:    Translation:Humans
  75. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology. 1993 Oct; 43(10):2073-9. PMID: 8413970.
    Citations: 55     Fields:    Translation:Humans
  76. Caday CG, Sklar RM, Berlove DJ, Kemmou A, Brown RH, Finklestein SP. Polyubiquitin gene expression following cerebral ischemia. Ann N Y Acad Sci. 1993 May 28; 679:188-94. PMID: 8390143.
    Citations: 2     Fields:    Translation:Animals
  77. Nozaki K, Finklestein SP, Beal MF. Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats. Eur J Pharmacol. 1993 Mar 02; 232(2-3):295-7. PMID: 8467865.
    Citations: 4     Fields:    Translation:Animals
  78. Nozaki K, Finklestein SP, Beal MF. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab. 1993 Mar; 13(2):221-8. PMID: 8436614.
    Citations: 16     Fields:    Translation:Animals
  79. Freese A, Finklestein SP, DiFiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 1992 Mar 20; 575(2):351-5. PMID: 1349256.
    Citations: 10     Fields:    Translation:AnimalsCells
  80. Powell PP, Finklestein SP, Dionne CA, Jaye M, Klagsbrun M. Temporal, differential and regional expression of mRNA for basic fibroblast growth factor in the developing and adult rat brain. Brain Res Mol Brain Res. 1991 Aug; 11(1):71-7. PMID: 1662747.
    Citations: 10     Fields:    Translation:Animals
  81. Finklestein SP, Caday CG, Kano M, Berlove DJ, Hsu CY, Moskowitz M, Klagsbrun M. Growth factor expression after stroke. Stroke. 1990 Nov; 21(11 Suppl):III122-4. PMID: 2237969.
    Citations: 4     Fields:    Translation:Animals
  82. Caday CG, Klagsbrun M, Fanning PJ, Mirzabegian A, Finklestein SP. Fibroblast growth factor (FGF) levels in the developing rat brain. Brain Res Dev Brain Res. 1990 Mar 01; 52(1-2):241-6. PMID: 2331791.
    Citations: 12     Fields:    Translation:Animals
  83. Finklestein SP, Fanning PJ, Caday CG, Powell PP, Foster J, Clifford EM, Klagsbrun M. Increased levels of basic fibroblast growth factor (bFGF) following focal brain injury. Restor Neurol Neurosci. 1990 Jan 01; 1(6):387-94. PMID: 21551582.
    Citations: 1     Fields:    
  84. Perrone-Bizzozero NI, Benowitz LI, Apostolides PJ, Franck ER, Finklestein SP, Bizzozero OA. Protein fatty acid acylation in developing cortical neurons. J Neurochem. 1989 Apr; 52(4):1149-55. PMID: 2926394.
    Citations: 2     Fields:    Translation:AnimalsCells
  85. Benowitz LI, Perrone-Bizzozero NI, Finklestein SP, Bird ED. Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex. J Neurosci. 1989 Mar; 9(3):990-5. PMID: 2466968.
    Citations: 13     Fields:    Translation:Humans
  86. Caday CG, Apostolides PJ, Benowitz LI, Perrone-Bizzozero NI, Finklestein SP. Partial purification and characterization of a neurite-promoting factor from the injured goldfish optic nerve. Brain Res Mol Brain Res. 1989 Jan; 5(1):45-50. PMID: 2927282.
    Citations:    Fields:    Translation:AnimalsCells
  87. Teicher MH, Lawrence JM, Barber NI, Finklestein SP, Lieberman HR, Baldessarini RJ. Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations. Arch Gen Psychiatry. 1988 Oct; 45(10):913-7. PMID: 3421804.
    Citations: 12     Fields:    Translation:Humans
  88. Finklestein SP, Apostolides PJ, Caday CG, Prosser J, Philips MF, Klagsbrun M. Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res. 1988 Sep 20; 460(2):253-9. PMID: 3224261.
    Citations: 47     Fields:    Translation:Animals
  89. Cohen BM, Buonanno F, Keck PE, Finklestein SP, Benes FM. Comparison of MRI and CT scans in a group of psychiatric patients. Am J Psychiatry. 1988 Sep; 145(9):1084-8. PMID: 3414850.
    Citations: 1     Fields:    Translation:Humans
  90. Finklestein SP, Apostolides PJ, Caday CG, Philips MF, Perrone-Bizzozero NI, Benowitz LI. A factor from the injured lower vertebrate CNS promotes outgrowth from human fetal brain neurons. Brain Res. 1988 May 17; 448(2):346-50. PMID: 3378156.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  91. Benowitz LI, Apostolides PJ, Perrone-Bizzozero N, Finklestein SP, Zwiers H. Anatomical distribution of the growth-associated protein GAP-43/B-50 in the adult rat brain. J Neurosci. 1988 Jan; 8(1):339-52. PMID: 3339416.
    Citations: 50     Fields:    Translation:Animals
  92. Finklestein SP, Weintraub RJ, Karmouz N, Askinazi C, Davar G, Baldessarini RJ. Antidepressant drug treatment for poststroke depression: retrospective study. Arch Phys Med Rehabil. 1987 Nov; 68(11):772-6. PMID: 3675174.
    Citations: 3     Fields:    Translation:Humans
  93. Neve RL, Perrone-Bizzozero NI, Finklestein S, Zwiers H, Bird E, Kurnit DM, Benowitz LI. The neuronal growth-associated protein GAP-43 (B-50, F1): neuronal specificity, developmental regulation and regional distribution of the human and rat mRNAs. Brain Res. 1987 Jul; 388(2):177-83. PMID: 3620911.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  94. Finklestein SP, Benowitz LI, Olson AJ, Perrone-Bizzozero NI, Majocha RE, Apostolides PJ. Conditioned media from the injured lower vertebrate CNS promote neurite outgrowth from mammalian brain neurons in vitro. Brain Res. 1987 Jun 16; 413(2):267-74. PMID: 3607477.
    Citations: 3     Fields:    Translation:AnimalsCells
  95. Benowitz LI, Perrone-Bizzozero NI, Finklestein SP. Molecular properties of the growth-associated protein GAP-43 (B-50). J Neurochem. 1987 May; 48(5):1640-7. PMID: 3559571.
    Citations: 16     Fields:    Translation:Animals
  96. Perrone-Bizzozero NI, Finklestein SP, Benowitz LI. Synthesis of a growth-associated protein by embryonic rat cerebrocortical neurons in vitro. J Neurosci. 1986 Dec; 6(12):3721-30. PMID: 2947982.
    Citations: 11     Fields:    Translation:AnimalsCells
  97. Baldessarini RJ, Kula NS, Francoeur D, Finklestein SP, Murphy F, Neumeyer JL. Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue. Life Sci. 1986 Nov 10; 39(19):1765-77. PMID: 3490612.
    Citations:    Fields:    Translation:AnimalsCells
  98. Teicher MH, Barber NI, Reichheld JH, Baldessarini RJ, Finklestein SP. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat. Brain Res. 1986 Nov; 395(1):124-8. PMID: 2430678.
    Citations: 6     Fields:    Translation:Animals
  99. Moya KL, Benowitz LI, Levine DN, Finklestein S. Covariant defects in visuospatial abilities and recall of verbal narrative after right hemisphere stroke. Cortex. 1986 Sep; 22(3):381-97. PMID: 3769493.
    Citations: 4     Fields:    Translation:Humans
  100. Baldessarini RJ, Kula NS, Francoeur D, Finklestein SP. Antioxidants fail to inhibit depletion of striatal dopamine by MPTP. Neurology. 1986 May; 36(5):735. PMID: 3486381.
    Citations: 2     Fields:    Translation:Animals
  101. Teicher MH, Lawrence JM, Barber NI, Finklestein SP, Lieberman H, Baldessarini RJ. Altered locomotor activity in neuropsychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 1986; 10(6):755-61. PMID: 3809527.
    Citations: 5     Fields:    Translation:Humans
  102. Finklestein S, Campbell A, Baldessarini RJ, Moya KL, Haber SN. Late changes in cerebral monoamine metabolism following focal ventrolateral cerebrocortical lesions in rats. Brain Res. 1985 Oct 07; 344(2):205-10. PMID: 2412650.
    Citations: 2     Fields:    Translation:Animals
  103. Kula NS, Baldessarini RJ, Campbell A, Finklestein S, Ram VJ, Neumeyer JL. Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species. Life Sci. 1984 Jun 25; 34(26):2567-75. PMID: 6610812.
    Citations:    Fields:    Translation:HumansAnimalsCells
  104. Stoll AL, Baldessarini RJ, Cohen BM, Finklestein SP. Assay of plasma thioridazine and metabolites by high-performance liquid chromatography with amperometric detection. J Chromatogr. 1984 May 11; 307(2):457-63. PMID: 6736194.
    Citations: 5     Fields:    Translation:Humans
  105. Rosen GD, Finklestein S, Stoll AL, Yutzey DA, Denenberg VH. Neonatal tail posture and its relationship to striatal dopamine asymmetry in the rat. Brain Res. 1984 Apr 16; 297(2):305-8. PMID: 6539141.
    Citations: 2     Fields:    Translation:HumansAnimals
  106. Rosen GD, Finklestein S, Stoll AL, Yutzey DA, Denenberg VH. Neurochemical asymmetries in the albino rat's cortex, striatum, and nucleus accumbens. Life Sci. 1984 Mar 19; 34(12):1143-8. PMID: 6200745.
    Citations: 10     Fields:    Translation:Animals
  107. Ackerman RH, Alpert NM, Correia JA, Finklestein S, Davis SM, Kelley RE, Donnan GA, D'Alton JG, Taveras JM. Positron imaging in ischemic stroke disease. Ann Neurol. 1984; 15 Suppl:S126-30. PMID: 6611112.
    Citations: 1     Fields:    Translation:Humans
  108. Finklestein S, Campbell A, Stoll AL, Baldessarini RJ, Stinus L, Paskevitch PA, Domesick VB. Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat. Brain Res. 1983 Jul 25; 271(2):279-88. PMID: 6193832.
    Citations: 3     Fields:    Translation:Animals
  109. Baldessarini RJ, Finklestein S, Arana GW. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry. 1983 May; 40(5):569-73. PMID: 6838334.
    Citations: 35     Fields:    Translation:Humans
  110. Finklestein S, Benowitz LI, Baldessarini RJ, Arana GW, Levine D, Woo E, Bear D, Moya K, Stoll AL. Mood, vegetative disturbance, and dexamethasone suppression test after stroke. Ann Neurol. 1982 Nov; 12(5):463-8. PMID: 6960804.
    Citations: 8     Fields:    Translation:Humans
  111. Finklestein S, Miller A, Callahan RJ, Fallon JT, Godley F, Feldman BL, Hinton RC, Roberts AB, Strauss HW, Lees RS. Imaging of acute arterial injury with 111In-labeled platelets: a comparison with scanning electron micrographs. Radiology. 1982 Oct; 145(1):155-9. PMID: 7122873.
    Citations:    Fields:    Translation:AnimalsCells
  112. Finklestein S, Alpert NM, Ackerman RH, Correia JA, Buonanno FS, Chang J, Brownell GL, Taveras JM. Positron brain imaging--normal patterns and asymmetries. Brain Cogn. 1982 Jul; 1(3):286-93. PMID: 6985441.
    Citations:    Fields:    Translation:Humans
  113. Levine DN, Finklestein S. Delayed psychosis after right temporoparietal stroke or trauma: relation to epilepsy. Neurology. 1982 Mar; 32(3):267-73. PMID: 6801540.
    Citations: 20     Fields:    Translation:Humans
  114. Alpert NM, Chesler DA, Correia JA, Ackerman RH, Chang JY, Finklestein S, Davis SM, Brownell GL, Taveras JM. Estimation of the local statistical noise in emission computed tomography. IEEE Trans Med Imaging. 1982; 1(2):142-6. PMID: 18238267.
    Citations: 11     Fields:    
  115. Finklestein S, Kleinman GM, Cuneo R, Baringer JR. Delayed stroke following carotid occlusion. Neurology. 1980 Jan; 30(1):84-8. PMID: 7188640.
    Citations: 9     Fields:    Translation:Humans
  116. Finklestein S, Alpert NM, Ackerman RH, Buonanno FS, Correia JA, Chang J, Kulas S, Brownell GL, Taveras JM. Positron imaging of the normal brain--regional patterns of cerebral blood flow and metabolism. Trans Am Neurol Assoc. 1980; 105:8-10. PMID: 6983753.
    Citations:    Fields:    Translation:Humans
  117. Finklestein S, Ropper A. The diagnosis of coma: its pitfalls and limitations. Heart Lung. 1979 Nov-Dec; 8(6):1059-64. PMID: 259060.
    Citations:    Fields:    Translation:Humans
  118. Caronna JJ, Finklestein S. Neurological syndromes after cardiac arrest. Stroke. 1978 Sep-Oct; 9(5):517-20. PMID: 705835.
    Citations: 2     Fields:    Translation:Humans
  119. Barnes BD, Finklestein S, Winestock DP. Radionuclide angiography: a sensitive diagnostic test for anterior circulation ischemia. Neurology. 1978 Aug; 28(8):775-81. PMID: 567294.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Finklestein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (469)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.